CSHL 2022 Glia in Health & Disease Conference
CSHL 2022 神经胶质细胞健康
基本信息
- 批准号:10387663
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:Action PotentialsAdvanced DevelopmentAgingAlzheimer&aposs DiseaseAreaAxonBehaviorBiochemistryBiological ModelsBiologyBlood VesselsBlood flowBrainCell physiologyCellsCellular biologyChronicCicatrixCommunitiesDataDevelopmentDiseaseEnsureEnvironmentEtiologyFacultyFosteringFunctional disorderFutureGene MutationGenesGeneticGoalsHealthHumanImageImaging technologyIndustryInflammationInflammatoryInjuryInternationalInvertebratesLaboratoriesLeadLength of StayLinkMetabolicMethodologyMinorityMolecularMolecular BiologyMolecular GeneticsMultiple SclerosisMutationNatural regenerationNerve RegenerationNervous System PhysiologyNeurodegenerative DisordersNeurogliaNeuronsNeurophysiology - biologic functionNeurotransmittersOralParticipantPhysiologyPlayPostdoctoral FellowResearchResearch InstituteResearch PersonnelRoleScheduleScientistSeriesSignal TransductionSynapsesSynaptic plasticitySystemWomanWorkbasegenetic manipulationgraduate studenthuman diseasehuman tissueimaging approachinterestlaboratory facilitymeetingsmembernervous system developmentnervous system disorderneural circuitnew therapeutic targetnotch proteinnovel strategiesnovel therapeutic interventionnovel therapeuticspostersrelating to nervous systemrepairedsuccesssymposiumtherapeutic targettissue repairtoolunpublished worksvirtual
项目摘要
2022 Cold Spring Harbor Laboratory Conference
GLIA IN HEALTH & DISEASE
Abstract
The proposed meeting on Glia in Health & Disease will be held at Cold Spring Harbor
Laboratory from July 21 – 25, 2022. The goal of this conference is to provide an active forum for
exchange of results in the rapidly advancing fields of glial biology and neuron-glia interactions.
Glial cells comprise a diverse group of non-neuronal cells that are essential for nervous system
development, circuit function, and neurological disease. These cells perform many important
roles, such as sculpting developing circuits, regulating neurotransmitter signaling between
neurons, providing metabolic support to neurons and other glial cells, supporting the fast and
efficient propagation of action potentials, modulating vascular development and blood flow, and
regulating inflammatory cascades in disease. With the advancement of genetic tools to
specifically target glia, we are now gaining a deeper mechanistic understanding of these and
other glial cell functions in health and disease. This includes a new realization that glia actively
modulate neural circuit function, plasticity, and behavior under healthy, steady-state conditions.
We are also now appreciating how these functions go awry in disease, leading to circuit
dysfunction, chronic inflammation, and destruction of neurons and their synaptic connections.
There are also clear indications that glia may not only react to diseased neurons to propagate
disease, but they are a part of the underlying etiology. For example, many gene mutations
linked to neurodegenerative diseases, such as Alzheimer's disease and multiple sclerosis (MS),
are in genes enriched in glia. Further genetic manipulation studies are beginning to reveal how
these mutations alter glial cell function and contribute to disease. Adding to the complexity in
disease, glia can also be beneficial and promote regeneration and tissue repair by performing
functions such as providing metabolic support, engulfing debris, and forming protective glial
scars. This meeting will highlight the latest developments in glial cell biology obtained through
studies of invertebrate and vertebrate model systems, as well as human tissue and cells, using
the most up-to-date genetics, molecular biology, biochemistry, physiology, and imaging
technologies. Using the goals and format of the eight prior extremely successful meetings as a
guide, we plan to: 1) assemble an international meeting of scientists engaged in studies of glial
biology and neuron-glia interactions; 2) discuss new and exciting developments in the field by
selecting talks from openly submitted abstracts on the basis of scientific merit; 3) provide an
opportunity for junior scientists of diverse backgrounds to present their data and engage in
scientific discourse with more established investigators; and 4) promote collaborative
interactions to accelerate the pace of discovery and identify novel approaches to better
understand nervous system function and, ultimately, target glial cells to treat neurological
diseases.
2022年冷泉港实验室会议
健康与疾病的神经胶质
抽象的
拟议的有关健康与疾病神经胶质的会议将在冷春港举行
从2022年7月21日至25日的实验室。这次会议的目标是为
在神经胶质生物学和神经胶质相互作用的迅速发展领域的结果交换。
神经胶质细胞包括一组对神经系统必不可少的非神经元细胞的潜水
发育,电路功能和神经疾病。这些细胞执行许多重要
角色,例如雕刻开发电路,调节神经递质信号传导
神经元,为神经元和其他神经胶质细胞提供代谢支持,支持快速和
有效地传播动作电位,调节血管发育和血流,以及
调节疾病中的炎症级联反应。随着遗传工具的发展
特别是针对神经胶质的,我们现在正在对它们进行更深入的机械理解,并且
其他神经胶质细胞在健康和疾病中起作用。这包括一个新的认识,即神经胶质积极
调节在健康,稳态条件下的神经回路功能,可塑性和行为。
我们现在也很欣赏这些功能如何在疾病中出现问题,导致电路
神经元及其突触连接的功能障碍,慢性炎症和破坏。
还有清楚的迹象表明,神经胶质不仅可能对脱离神经元反应以传播
疾病,但它们是基本病因的一部分。例如,许多基因突变
与神经退行性疾病有关,例如阿尔茨海默氏病和多发性硬化症(MS),
在富含神经胶质的基因中。进一步的遗传操纵研究开始揭示
这些突变改变了神经胶质细胞功能并有助于疾病。增加复杂性
疾病,神经胶质也可能是有益的,并通过执行来促进再生和组织修复
诸如提供代谢支持,吞噬碎片和形成保护性神经胶质等功能
疤痕。这次会议将强调通过
使用无脊椎动物和脊椎动物模型系统以及人体组织和细胞的研究,使用
最新的遗传学,分子生物学,生物化学,生理学和成像
技术。使用八个先前的极其成功的会议的目标和格式作为
指南,我们计划:1)组建一场从事神经胶质研究的科学家会议
生物学和神经胶质相互作用; 2)讨论该领域的新事态发展
根据科学功绩从公开提交的摘要中选择谈判; 3)提供一个
潜水员背景的初级科学家提供数据并参与的机会
与更既定的研究人员的科学论述; 4)促进合作
相互作用以加速发现空间并确定新颖的方法以更好
了解神经系统功能,并最终靶向神经胶质细胞以治疗神经系统
疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID J. STEWART其他文献
DAVID J. STEWART的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID J. STEWART', 18)}}的其他基金
CSHL Single Cell Analysis Course (2023-2027)
CSHL单细胞分析课程(2023-2027)
- 批准号:
10627446 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
CSHL 2023 Eukaryotic mRNA Processing Conference
CSHL 2023真核mRNA加工会议
- 批准号:
10679367 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
CSHL 2023 Eukaryotic DNA Replication and Genome Maintenance Conference
CSHL 2023真核DNA复制与基因组维护会议
- 批准号:
10677192 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
CSHL 2023 Conference on Biology of Cancer: Microenvironment & Metastasis
CSHL 2023癌症生物学会议:微环境
- 批准号:
10750261 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
CSHL 2023 Mechanisms of Metabolic Signaling Conference
CSHL 2023代谢信号机制会议
- 批准号:
10751346 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
CSHL 2023 Neurobiology of Drosophila Conference
CSHL 2023果蝇神经生物学会议
- 批准号:
10669936 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
CSHL The Biology of Genomes Conference (2023-2027)
CSHL基因组生物学会议(2023-2027)
- 批准号:
10608266 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
CSHL 2023 Conference on Microbial Pathogenesis & Host Response
CSHL 2023微生物发病机制会议
- 批准号:
10675902 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
相似国自然基金
CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
- 批准号:32100463
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
发展高级固体核磁方法探索功能材料的表界面化学
- 批准号:21922410
- 批准年份:2019
- 资助金额:120 万元
- 项目类别:优秀青年科学基金项目
TACSTD2在卵巢高级别浆液性癌发生发展中的作用及分子机制研究
- 批准号:81402157
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Harnessing Motoneuron Activity: From Lab to Clinic
利用运动神经元活动:从实验室到诊所
- 批准号:
7236418 - 财政年份:2007
- 资助金额:
$ 2.3万 - 项目类别:
Harnessing Motoneuron Activity: From Lab to Clinic
利用运动神经元活动:从实验室到诊所
- 批准号:
7433213 - 财政年份:2007
- 资助金额:
$ 2.3万 - 项目类别:
Harnessing Motoneuron Activity: From Lab to Clinic
利用运动神经元活动:从实验室到诊所
- 批准号:
8079038 - 财政年份:2007
- 资助金额:
$ 2.3万 - 项目类别:
Harnessing Motoneuron Activity: From Lab to Clinic
利用运动神经元活动:从实验室到诊所
- 批准号:
7860691 - 财政年份:2007
- 资助金额:
$ 2.3万 - 项目类别:
Harnessing Motoneuron Activity: From Lab to Clinic
利用运动神经元活动:从实验室到诊所
- 批准号:
7637376 - 财政年份:2007
- 资助金额:
$ 2.3万 - 项目类别: